Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
by from Morbidity and Mortality Weekly Report (MMWR) on (#5PTEK)
This report describes ACIP's standard recommendation for the Pfizer-BioNTech COVID-19vaccine in persons 16 years or older.